Literature DB >> 34028750

Animal and Human Models of Tissue Repair and Fibrosis: An Introduction.

David Lagares1,2,3, Boris Hinz4.   

Abstract

Reductionist cell culture systems are not only convenient but essential to understand molecular mechanisms of myofibroblast activation and action in carefully controlled conditions. However, tissue myofibroblasts do not act in isolation and the complexity of tissue repair and fibrosis in humans cannot be captured even by the most elaborate culture models. Over the past five decades, numerous animal models have been developed to study different aspects of myofibroblast biology and interactions with other cells and extracellular matrix. The underlying principles can be broadly classified into: (1) organ injury by trauma such as prototypical full thickness skin wounds or burns; (2) mechanical challenges, such as pressure overload of the heart by ligature of the aorta or the pulmonary vein; (3) toxic injury, such as administration of bleomycin to lungs and carbon tetrachloride to the liver; (4) organ infection with viruses, bacteria, and parasites, such as nematode infections of liver; (5) cytokine and inflammatory models, including local delivery or viral overexpression of active transforming growth factor beta; (6) "lifestyle" and metabolic models such as high-fat diet; and (7) various genetic models. We will briefly summarize the most widely used mouse models used to study myofibroblasts in tissue repair and fibrosis as well as genetic tools for manipulating myofibroblast repair functions in vivo.

Entities:  

Keywords:  Fibrosis; Infection; Inflammation; Injury; Mechanical overload; Mouse models; Myofibroblast; Toxins

Year:  2021        PMID: 34028750     DOI: 10.1007/978-1-0716-1382-5_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  104 in total

1.  Can a biologist fix a radio?--Or, what I learned while studying apoptosis.

Authors:  Yuri Lazebnik
Journal:  Cancer Cell       Date:  2002-09       Impact factor: 31.743

2.  Mesenchymal stem cell mechanobiology and emerging experimental platforms.

Authors:  Luke MacQueen; Yu Sun; Craig A Simmons
Journal:  J R Soc Interface       Date:  2013-05-01       Impact factor: 4.118

Review 3.  Recapitulating human tissue damage, repair, and fibrosis with human pluripotent stem cell-derived organoids.

Authors:  Maria F Sobral-Reyes; Dario R Lemos
Journal:  Stem Cells       Date:  2019-12-09       Impact factor: 6.277

Review 4.  Engineered cell and tissue models of pulmonary fibrosis.

Authors:  Aswin Sundarakrishnan; Ying Chen; Lauren D Black; Bree B Aldridge; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2017-12-18       Impact factor: 15.470

5.  Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices.

Authors:  Haude Clouzeau-Girard; Christelle Guyot; Chantal Combe; Valérie Moronvalle-Halley; Chantal Housset; Thierry Lamireau; Jean Rosenbaum; Alexis Desmoulière
Journal:  Lab Invest       Date:  2006-03       Impact factor: 5.662

Review 6.  Engineering in vitro models of hepatofibrogenesis.

Authors:  Giuseppe Mazza; Walid Al-Akkad; Krista Rombouts
Journal:  Adv Drug Deliv Rev       Date:  2017-05-31       Impact factor: 15.470

7.  Reconstitution of skin fibrosis development using a tissue engineering approach.

Authors:  Véronique J Moulin
Journal:  Methods Mol Biol       Date:  2013

8.  Fibrotic microtissue array to predict anti-fibrosis drug efficacy.

Authors:  Mohammadnabi Asmani; Sanjana Velumani; Yan Li; Nicole Wawrzyniak; Isaac Hsia; Zhaowei Chen; Boris Hinz; Ruogang Zhao
Journal:  Nat Commun       Date:  2018-05-25       Impact factor: 14.919

9.  A Bioreactor Technology for Modeling Fibrosis in Human and Rodent Precision-Cut Liver Slices.

Authors:  Hannah L Paish; Lee H Reed; Helen Brown; Mark C Bryan; Olivier Govaere; Jack Leslie; Ben S Barksby; Marina Garcia Macia; Abigail Watson; Xin Xu; Marco Y W Zaki; Laura Greaves; Julia Whitehall; Jeremy French; Steven A White; Derek M Manas; Stuart M Robinson; Gabriele Spoletini; Clive Griffiths; Derek A Mann; Lee A Borthwick; Michael J Drinnan; Jelena Mann; Fiona Oakley
Journal:  Hepatology       Date:  2019-05-28       Impact factor: 17.425

10.  Making microenvironments: A look into incorporating macromolecular crowding into in vitro experiments, to generate biomimetic microenvironments which are capable of directing cell function for tissue engineering applications.

Authors:  Paula Benny; Michael Raghunath
Journal:  J Tissue Eng       Date:  2017-10-06       Impact factor: 7.813

View more
  2 in total

1.  Total glucosides of paeony inhibits liver fibrosis and inflammatory response associated with cirrhosis via the FLI1/NLRP3 axis.

Authors:  Jie Zhang; Yiwei Fu; Bin Yang; Xiaoxing Xiang
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Editorial: Fibrosis and Inflammation in Tissue Pathophysiology.

Authors:  Isotta Chimenti; Susanne Sattler; Gonzalo Del Monte-Nieto; Elvira Forte
Journal:  Front Physiol       Date:  2022-01-21       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.